NCT07740538

Brief Summary

The prevalence and causes of malnutrition and sarcopenia in children and adolescents with Primary ciliary dyskinesia (PCD) have not been sufficiently elucidated. The aim of this study is to investigate the prevalence of malnutrition and sarcopenia in children and adolescents with PCD.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
23mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

August 3, 2026

Expected
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

11 months

First QC Date

July 23, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

MalnutritionMuscle strengthSarcopeniaRespiratory function testPrimary Ciliary Dyskinesia

Outcome Measures

Primary Outcomes (1)

  • Handgrip Muscle Strength in Participants

    Bilateral grip strength in children and adolescents with PCD will be measured in kgF using a hand dynamometer.

    From enrollment to the end of treatment at 1 year

Secondary Outcomes (20)

  • Malnutrition risk score in Participants

    From enrollment to the end of treatment at 1 year

  • Body Weight

    From enrollment to the end of treatment at 1 year

  • Height

    From enrollment to the end of treatment at 1 year

  • Body Mass Index

    From enrollment to the end of treatment at 1 year

  • Waist circumference

    From enrollment to the end of treatment at 1 year

  • +15 more secondary outcomes

Study Arms (1)

Patient of Primary Ciliary Dyskinesia

The study will include children and adolescents with PCD aged 6 to 18 (n=15).

Other: Physical assessments of individuals

Interventions

Participants will be evaluated in terms of nutritional status, anthropometric measurements (waist circumference, hip circumference, waist-to-height ratio, skinfold measurements) and body composition, pulmonary functions, anaerobic capacity, muscle strength.

Patient of Primary Ciliary Dyskinesia

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study will include children and adolescents aged 6-18 years with Primary Ciliary Dyskinesia (PCD).

You may qualify if:

  • Unexplained neonatal respiratory distress, lateralization defect, productive cough, bronchiectasis, daily nasal congestion, and pansinusitis, as well as laboratory tests such as high-speed video microscopy, transmission electron microscopy, or genetic testing according to the European Respiratory Society diagnostic guidelines.
  • Cooperative individuals,
  • Individuals who have never smoked
  • Willingness to participate in the study
  • \. Voluntary participation in the study

You may not qualify if:

  • Individuals with any acute, chronic, or systemic illness other than PCD
  • Individuals who smoke or are quitting smoking
  • Individuals who are not willing to participate in the study
  • Individuals who are uncooperative

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Democracy University

Izmir, 35140, Turkey (Türkiye)

Location

Related Publications (3)

  • Despotes KA, Zariwala MA, Davis SD, Ferkol TW. Primary Ciliary Dyskinesia: A Clinical Review. Cells. 2024 Jun 4;13(11):974. doi: 10.3390/cells13110974.

    PMID: 38891105BACKGROUND
  • McCoy J, Gatt D, Shaw M, Solomon M, Kritzinger F, Ratjen F. The Impact of Nutritional Status on Lung Function Trajectories in Pediatric Patients With Primary Ciliary Dyskinesia. Pediatr Pulmonol. 2026 Apr;61(4):e71634. doi: 10.1002/ppul.71634.

    PMID: 42001405BACKGROUND
  • Karavasiloglou N, Gkatzou V, Fernandez-Rodriguez A, Schwartz V, Goutaki M. Nutrition and growth of primary ciliary dyskinesia patients: a systematic review. Eur Respir Rev. 2026 May 27;35(180):260024. doi: 10.1183/16000617.0024-2026. Print 2026 Apr.

    PMID: 42203237BACKGROUND

MeSH Terms

Conditions

Ciliary Motility DisordersMalnutritionSarcopenia

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesCiliopathiesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornNutrition DisordersNutritional and Metabolic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Kerim K Göküstün, Dr. Lecturer

    Izmir Democracy University

    STUDY DIRECTOR
  • Gülşah BARĞI, Assoc. Dr.

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • Aybüke Sena DEMİR, MSc.

    Izmir Democracy University

    PRINCIPAL INVESTIGATOR
  • Ece OCAK, Dr.

    University of Health science

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kerim Kaan K GÖKÜSTÜN, Dr. Lecturer

CONTACT

Gülşah BARĞI, Assoc. Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 23, 2026

First Posted

July 31, 2026

Study Start (Estimated)

August 3, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations